PURPOSE. To formulate and test a model to predict the development of local patches of nonproliferative diabetic retinopathy (NPDR), based on multifocal electroretinogram (mfERG) implicit times and candidate diabetic risk factors. METHODS. mfERGs and fundus photographs were obtained from 28 eyes of 28 diabetic patients during an initial and 12- month followup examination. mfERG implicit times were derived at 103 locations using a template- stretching method, and a z- score was calculated in comparison with 20 age- matched normal subjects. Thirty- five nonoverlapping retinal zones were constructed by grouping two to three adjacent stimulated locations, and each zone was assigned the maximum z- score within it. Zones containing initial retinopathy were excluded from further analysis. The probability that new retinopathy would develop in the remaining zones by the follow- up examination was modeled based on the mfERG implicit time z- score for the zone and other candidate diabetic risk factors determined during the initial visit. Data collected from four previously untested diabetic subjects and the other eye of eight previous subjects during their second year follow- up were used to test the predictive model. RESULTS. After 1 year, new retinopathy developed in 11 of the 12 NPDR eyes and 1 of the 16 eyes without initial retinopathy. After accounting for the correlation among zones within each eye, a predictive model was formulated with the variables mfERG implicit time, duration of diabetes, presence of retinopathy (NPDR or no retinopathy), and blood glucose level, at initial visit. The area under the receiver operating characteristic (ROC) curve of this multivariate model is 0.90 (P < 0.001). The predictive model has an expected sensitivity of 86% and a specificity of 84% , which was verified by the test data. CONCLUSIONS. The development of diabetic retinopathy over a 1- year period can be well predicted by a multivariate model. The inclusion of local mfERG implicit times allowed the model to identify the specific sites of future retinopathy. PURPOSE. To formulate and test a model to predict the development of local patches of nonproliferative diabetic retinopathy (NPDR), based on multifocal electroretinogram (mfERG) implicit times and candidate diabetic risk factors. METHODS. MfERGs and fundus photographs were obtained from 28 eyes of 28 diabetic patients during an initial and 12- month follow up examination. MfERG implicit times were derived at 103 locations using a template-stretching method, and a z-score was calculated in comparison with 20 age-matched normal subjects. Thirty-five nonoverlapping retinal zones were constructed by grouping two to three adjacent stimulated locations, and each zone was assigned the maximum z- score within it. Zones containing initial retinopathy were excluded from further analysis. The probability that new retinopathy would develop in the remaining zones by the follow- up examination was modeled based on the mfERG implicit time z-score for the zone and other candidate diabetic risk fac tors determined during the initial visit. Data collected from four previously untested diabetic subjects and the other eye of eight previous subjects during their second year follow- up were used to test the predictive model. RESULTS. After 1 year, new retinopathy developed in 11 of the 12 NPDR eyes and 1 of the 16 eyes without initial retinopathy. After accounting for the correlation among zones within each eye, a predictive model was formulated with the variables mfERG implicit time, duration of diabetes, presence of retinopathy (NPDR or no retinopathy) , and blood glucose level, at initial visit. The area under the receiver operating characteristic (ROC) curve of this multivariate model is 0.90 (P <0.001). The predictive model has an expected sensitivity of 86% and a specificity of 84% which was verified by the test data. CONCLUSIONS. The development of diabetic retinopathy over a 1-year period can be well predicted by a multivariate model. The inclusion of local mfERG implicit times allowed the model to identify the specific sites of future retinopathy.